Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

NCT03086486 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

181

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary
Tuberculosis, Multidrug-Resistant
Tuberculosis, MDR
Tuberculosis
Extensively Drug-Resistant Tuberculosis
Pre-XDR-TB
XDR-TB

Interventions

DRUG: Pretomanid
DRUG: Linezolid
DRUG: Bedaquiline
DRUG: Placebo Linezolid

Sponsor

Global Alliance for TB Drug Development